Header Logo

Connection

Sara Vesely to Humans

Back to Details
This is a "connection" page, showing publications Sara Vesely has written about Humans.
Sara Vesely
Connection Strength
1.594
Humans
  1. Laboratory monitoring during pregnancy and post-partum hemorrhage in women with von Willebrand disease. J Thromb Haemost. 2020 03; 18(3):604-608.
    View in: PubMed
    Score: 0.039
  2. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
    View in: PubMed
    Score: 0.039
  3. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2019 Jun; 32(3):305-311.
    View in: PubMed
    Score: 0.037
  4. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 11 27; 2(22):3292-3316.
    View in: PubMed
    Score: 0.036
  5. The Predictive Influence of Youth Assets on Drinking and Driving Behaviors in Adolescence and Young Adulthood. J Prim Prev. 2016 Jun; 37(3):231-45.
    View in: PubMed
    Score: 0.031
  6. Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy. J Thromb Haemost. 2015 Jun; 13 Suppl 1:S216-22.
    View in: PubMed
    Score: 0.029
  7. Prospective associations among youth assets in young adults and tobacco use. Am J Prev Med. 2015 Jan; 48(1 Suppl 1):S94-S101.
    View in: PubMed
    Score: 0.028
  8. The influence of assets and environmental factors on gender differences in adolescent drug use. J Adolesc. 2014 Aug; 37(6):827-37.
    View in: PubMed
    Score: 0.027
  9. A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion. 2012 Jul; 52(7):1593-4; author reply 1594-5.
    View in: PubMed
    Score: 0.023
  10. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.023
  11. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e737S-e801S.
    View in: PubMed
    Score: 0.023
  12. Determinants of salivary cotinine concentrations among smokeless tobacco users. Nicotine Tob Res. 2012 Oct; 14(10):1229-34.
    View in: PubMed
    Score: 0.023
  13. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
    View in: PubMed
    Score: 0.021
  14. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33.
    View in: PubMed
    Score: 0.020
  15. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37.
    View in: PubMed
    Score: 0.017
  16. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
    View in: PubMed
    Score: 0.015
  17. Drug-induced thrombocytopenia: an updated systematic review. Ann Intern Med. 2005 Mar 15; 142(6):474-5.
    View in: PubMed
    Score: 0.014
  18. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58.
    View in: PubMed
    Score: 0.014
  19. The potential protective effects of youth assets from adolescent sexual risk behaviors. J Adolesc Health. 2004 May; 34(5):356-65.
    View in: PubMed
    Score: 0.013
  20. How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
    View in: PubMed
    Score: 0.013
  21. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
    View in: PubMed
    Score: 0.013
  22. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
    View in: PubMed
    Score: 0.013
  23. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
    View in: PubMed
    Score: 0.012
  24. Reports of drug-induced thrombocytopenia. Ann Intern Med. 2003 Feb 04; 138(3):239.
    View in: PubMed
    Score: 0.012
  25. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
    View in: PubMed
    Score: 0.012
  26. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.012
  27. Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura. Blood. 2022 08 18; 140(7):785-789.
    View in: PubMed
    Score: 0.012
  28. Idelalisib activates AKT via increased recruitment of PI3Kd/PI3Kß to BCR signalosome while reducing PDK1 in post-therapy CLL cells. Leukemia. 2022 07; 36(7):1806-1817.
    View in: PubMed
    Score: 0.012
  29. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2022 03; 143:91-104.
    View in: PubMed
    Score: 0.011
  30. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021 11 23; 5(22):4721-4726.
    View in: PubMed
    Score: 0.011
  31. Associations between number of lifetime partners and other health behaviors. Am J Health Behav. 2001 Nov-Dec; 25(6):537-44.
    View in: PubMed
    Score: 0.011
  32. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and treatment. Cleve Clin J Med. 2001 Oct; 68(10):857-8, 860, 863-4 passim.
    View in: PubMed
    Score: 0.011
  33. Self-reported positive impact of mentored clinical research training is associated with academic success in hematology. Blood Adv. 2021 07 27; 5(14):2919-2924.
    View in: PubMed
    Score: 0.011
  34. The Prevalence of Pelvic Floor Hematoma After Vaginal Delivery. Female Pelvic Med Reconstr Surg. 2021 06 01; 27(6):393-397.
    View in: PubMed
    Score: 0.011
  35. SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood Cancer J. 2021 05 17; 11(5):93.
    View in: PubMed
    Score: 0.011
  36. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 10; 138:115-127.
    View in: PubMed
    Score: 0.011
  37. GRADE notes: How to use GRADE when there is "no" evidence? A case study of the expert evidence approach. J Clin Epidemiol. 2021 09; 137:231-235.
    View in: PubMed
    Score: 0.011
  38. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 10; 18(10):2496-2502.
    View in: PubMed
    Score: 0.010
  39. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 10; 18(10):2503-2512.
    View in: PubMed
    Score: 0.010
  40. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 10; 18(10):2486-2495.
    View in: PubMed
    Score: 0.010
  41. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
    View in: PubMed
    Score: 0.010
  42. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 05 26; 4(10):2351-2365.
    View in: PubMed
    Score: 0.010
  43. Impact of gender and caregiving responsibilities on academic success in hematology. Blood Adv. 2020 02 25; 4(4):755-761.
    View in: PubMed
    Score: 0.010
  44. Prospective Associations Among Youth Religiosity and Religious Denomination and Youth Contraception Use. J Relig Health. 2020 Feb; 59(1):555-569.
    View in: PubMed
    Score: 0.010
  45. Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database. Anticancer Res. 2020 Feb; 40(2):847-855.
    View in: PubMed
    Score: 0.010
  46. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):55-61.
    View in: PubMed
    Score: 0.010
  47. Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. Gynecol Oncol. 2020 01; 156(1):100-106.
    View in: PubMed
    Score: 0.010
  48. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database. Oncologist. 2020 02; 25(2):e276-e283.
    View in: PubMed
    Score: 0.010
  49. Effect Modification of the Association Between Race and Stage at Colorectal Cancer Diagnosis by Socioeconomic Status. J Public Health Manag Pract. 2019 Sep/Oct; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years:S29-S35.
    View in: PubMed
    Score: 0.010
  50. Factors Associated with Treatment Failure and Radiosurgery-Related Edema in WHO Grade 1 and 2 Meningioma Patients Receiving Gamma Knife Radiosurgery. World Neurosurg. 2019 Oct; 130:e558-e565.
    View in: PubMed
    Score: 0.010
  51. Von Willebrand disease screening in women undergoing hysterectomy for heavy menstrual bleeding. Haemophilia. 2019 May; 25(3):e188-e191.
    View in: PubMed
    Score: 0.009
  52. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
    View in: PubMed
    Score: 0.009
  53. Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia. Am J Clin Oncol. 2019 02; 42(2):138-142.
    View in: PubMed
    Score: 0.009
  54. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151.
    View in: PubMed
    Score: 0.009
  55. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 2019 01; 94(1):E8-E11.
    View in: PubMed
    Score: 0.009
  56. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
    View in: PubMed
    Score: 0.009
  57. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43.
    View in: PubMed
    Score: 0.009
  58. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
    View in: PubMed
    Score: 0.009
  59. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 06; 131(6):1121-1129.
    View in: PubMed
    Score: 0.009
  60. Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes. Gynecol Oncol. 2018 04; 149(1):28-32.
    View in: PubMed
    Score: 0.009
  61. Adolescent Pregnancy Prevention Among Youths Living in Group Care Homes: A Cluster Randomized Controlled Trial. Am J Public Health. 2018 02; 108(S1):S38-S44.
    View in: PubMed
    Score: 0.009
  62. Adolescent Pregnancy Prevention in Group Homes: Recruiting and Retention Considerations. Am J Public Health. 2018 02; 108(S1):S9-S10.
    View in: PubMed
    Score: 0.009
  63. Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study. Lancet Haematol. 2018 Jan; 5(1):e44-e52.
    View in: PubMed
    Score: 0.009
  64. Mobile Application vs Paper Pictorial Blood Assessment Chart to Track Menses in Young Women: A Randomized Cross-over Design. J Pediatr Adolesc Gynecol. 2018 Apr; 31(2):84-88.
    View in: PubMed
    Score: 0.008
  65. Beyond the Effects of Comprehensive Sexuality Education: The Significant Prospective Effects of Youth Assets on Contraceptive Behaviors. J Adolesc Health. 2017 Dec; 61(6):678-684.
    View in: PubMed
    Score: 0.008
  66. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
    View in: PubMed
    Score: 0.008
  67. Demographic Factors Predict Disparities in Number of Assets Youth Possess. Am J Health Behav. 2017 Sep 01; 41(5):652-660.
    View in: PubMed
    Score: 0.008
  68. Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience. Anticancer Res. 2017 09; 37(9):5019-5025.
    View in: PubMed
    Score: 0.008
  69. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov; 92(11):1224-1232.
    View in: PubMed
    Score: 0.008
  70. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.008
  71. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
    View in: PubMed
    Score: 0.008
  72. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.008
  73. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One. 2017; 12(6):e0179117.
    View in: PubMed
    Score: 0.008
  74. Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17(7):450-456.e2.
    View in: PubMed
    Score: 0.008
  75. Response to Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238. Diabetes Care. 2017 05; 40(5):e62.
    View in: PubMed
    Score: 0.008
  76. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care. 2017 Feb; 40(2):233-238.
    View in: PubMed
    Score: 0.008
  77. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 10 27; 128(17):2175-2178.
    View in: PubMed
    Score: 0.008
  78. The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul Fibrinolysis. 2016 Sep; 27(6):648-52.
    View in: PubMed
    Score: 0.008
  79. Short-Term Impact of a Teen Pregnancy-Prevention Intervention Implemented in Group Homes. J Adolesc Health. 2016 11; 59(5):584-591.
    View in: PubMed
    Score: 0.008
  80. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
    View in: PubMed
    Score: 0.008
  81. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. Leukemia. 2017 02; 31(2):350-360.
    View in: PubMed
    Score: 0.008
  82. Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okla State Med Assoc. 2016 Jul-Aug; 109(7-8):391-398.
    View in: PubMed
    Score: 0.008
  83. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9.
    View in: PubMed
    Score: 0.008
  84. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
    View in: PubMed
    Score: 0.008
  85. Diversity and severity of adverse reactions to quinine: A systematic review. Am J Hematol. 2016 May; 91(5):461-6.
    View in: PubMed
    Score: 0.008
  86. Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc. 2015 Nov; 108(11):492-9.
    View in: PubMed
    Score: 0.007
  87. Patterns of Care for Localized Breast Cancer in Oklahoma, 2003-2006. Women Health. 2015; 55(8):975-95.
    View in: PubMed
    Score: 0.007
  88. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
    View in: PubMed
    Score: 0.007
  89. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies. Gynecol Oncol. 2015 Mar; 136(3):472-7.
    View in: PubMed
    Score: 0.007
  90. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10.
    View in: PubMed
    Score: 0.007
  91. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
    View in: PubMed
    Score: 0.007
  92. Prospective association between negative life events and initiation of sexual intercourse: the influence of family structure and family income. Am J Public Health. 2015 Mar; 105(3):598-604.
    View in: PubMed
    Score: 0.007
  93. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
    View in: PubMed
    Score: 0.007
  94. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
    View in: PubMed
    Score: 0.007
  95. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
    View in: PubMed
    Score: 0.007
  96. Prospective associations between negative life events and youth tobacco use. Am J Health Behav. 2014 Nov; 38(6):942-50.
    View in: PubMed
    Score: 0.007
  97. The predictive influence of family and neighborhood assets on fighting and weapon carrying from mid- to late adolescence. Prev Sci. 2014 Aug; 15(4):473-84.
    View in: PubMed
    Score: 0.007
  98. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
    View in: PubMed
    Score: 0.007
  99. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.007
  100. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80.
    View in: PubMed
    Score: 0.006
  101. A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence. Addict Behav. 2014 Mar; 39(3):622-9.
    View in: PubMed
    Score: 0.006
  102. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
    View in: PubMed
    Score: 0.006
  103. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81.
    View in: PubMed
    Score: 0.006
  104. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
    View in: PubMed
    Score: 0.006
  105. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol. 2013 Sep; 130(3):411-5.
    View in: PubMed
    Score: 0.006
  106. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
    View in: PubMed
    Score: 0.006
  107. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013 May 30; 121(22):4457-62.
    View in: PubMed
    Score: 0.006
  108. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
    View in: PubMed
    Score: 0.006
  109. A longitudinal study of youth assets, neighborhood conditions, and youth sexual behaviors. J Adolesc Health. 2013 Jun; 52(6):779-85.
    View in: PubMed
    Score: 0.006
  110. The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie. 2013 May 29; 33(2):105-12.
    View in: PubMed
    Score: 0.006
  111. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7.
    View in: PubMed
    Score: 0.006
  112. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
    View in: PubMed
    Score: 0.006
  113. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
    View in: PubMed
    Score: 0.006
  114. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88.
    View in: PubMed
    Score: 0.006
  115. School-related assets and youth risk behaviors: alcohol consumption and sexual activity. J Sch Health. 2012 Jan; 82(1):3-10.
    View in: PubMed
    Score: 0.006
  116. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303.
    View in: PubMed
    Score: 0.006
  117. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
    View in: PubMed
    Score: 0.006
  118. Parental youth assets and sexual activity: differences by race/ethnicity. Am J Health Behav. 2011 Sep; 35(5):513-24.
    View in: PubMed
    Score: 0.006
  119. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets. Transfusion. 2011 Dec; 51(12):2690-4.
    View in: PubMed
    Score: 0.005
  120. Associations between youth assets and sexual intercourse by household income. Am J Health Promot. 2011 May-Jun; 25(5):301-9.
    View in: PubMed
    Score: 0.005
  121. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
    View in: PubMed
    Score: 0.005
  122. Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav. 2011 Jan-Feb; 35(1):28-39.
    View in: PubMed
    Score: 0.005
  123. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7.
    View in: PubMed
    Score: 0.005
  124. Reliability and validity of the youth asset survey: an update. Am J Health Promot. 2010 Sep-Oct; 25(1):e13-24.
    View in: PubMed
    Score: 0.005
  125. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
    View in: PubMed
    Score: 0.005
  126. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662.
    View in: PubMed
    Score: 0.005
  127. Youth assets and sexual risk behavior: differences between male and female adolescents. Health Educ Behav. 2010 Jun; 37(3):343-56.
    View in: PubMed
    Score: 0.005
  128. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.005
  129. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7.
    View in: PubMed
    Score: 0.005
  130. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37.
    View in: PubMed
    Score: 0.005
  131. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.005
  132. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.
    View in: PubMed
    Score: 0.005
  133. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009 Mar 03; 150(5):293-300.
    View in: PubMed
    Score: 0.005
  134. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101.
    View in: PubMed
    Score: 0.005
  135. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87.
    View in: PubMed
    Score: 0.005
  136. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4.
    View in: PubMed
    Score: 0.005
  137. Methodological considerations in a community-based longitudinal study. Am J Health Behav. 2009 Jan-Feb; 33(1):58-68.
    View in: PubMed
    Score: 0.005
  138. Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6.
    View in: PubMed
    Score: 0.005
  139. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma. 2009; 56(4):298-302.
    View in: PubMed
    Score: 0.005
  140. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
    View in: PubMed
    Score: 0.005
  141. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008 Nov 15; 112(10):4003-8.
    View in: PubMed
    Score: 0.004
  142. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
    View in: PubMed
    Score: 0.004
  143. Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J. 2008 Jul; 12 Suppl 1:82-90.
    View in: PubMed
    Score: 0.004
  144. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86.
    View in: PubMed
    Score: 0.004
  145. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9.
    View in: PubMed
    Score: 0.004
  146. Accuracy of step recording in free-living adults. Res Q Exerc Sport. 2007 Dec; 78(5):542-7.
    View in: PubMed
    Score: 0.004
  147. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion. 2008 Feb; 48(2):382-92.
    View in: PubMed
    Score: 0.004
  148. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
    View in: PubMed
    Score: 0.004
  149. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
    View in: PubMed
    Score: 0.004
  150. Associations between youth assets and sexual activity: does adult supervision play a role? Child Care Health Dev. 2007 Jul; 33(4):448-54.
    View in: PubMed
    Score: 0.004
  151. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43.
    View in: PubMed
    Score: 0.004
  152. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
    View in: PubMed
    Score: 0.004
  153. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 2007 May; 100(5):512-4.
    View in: PubMed
    Score: 0.004
  154. A matched case-control study: investigating the relationship between youth assets and sexual intercourse among 13- to 14-year-olds. Child Care Health Dev. 2007 Jan; 33(1):40-4.
    View in: PubMed
    Score: 0.004
  155. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
    View in: PubMed
    Score: 0.004
  156. Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf. 2007; 30(2):185-6.
    View in: PubMed
    Score: 0.004
  157. Youth assets and sexual abstinence in Native American youth. J Health Care Poor Underserved. 2006 Nov; 17(4):775-88.
    View in: PubMed
    Score: 0.004
  158. Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med. 2006 Jul-Aug; 38(7):500-4.
    View in: PubMed
    Score: 0.004
  159. Parental communication and youth sexual behaviour. J Adolesc. 2007 Jun; 30(3):449-66.
    View in: PubMed
    Score: 0.004
  160. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6.
    View in: PubMed
    Score: 0.004
  161. Youth assets, aggression, and delinquency within the context of family structure. Am J Health Behav. 2005 Nov-Dec; 29(6):557-68.
    View in: PubMed
    Score: 0.004
  162. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6.
    View in: PubMed
    Score: 0.004
  163. Relationships among youth assets and neighborhood and community resources. Health Educ Behav. 2005 Jun; 32(3):380-97.
    View in: PubMed
    Score: 0.004
  164. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Jul; 90(7):4112-4.
    View in: PubMed
    Score: 0.004
  165. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
    View in: PubMed
    Score: 0.003
  166. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004 Sep-Oct; 17(5):309-18.
    View in: PubMed
    Score: 0.003
  167. The association between multiple youth assets and sexual behavior. Am J Health Promot. 2004 Sep-Oct; 19(1):12-8.
    View in: PubMed
    Score: 0.003
  168. The potential protective effect of youth assets on adolescent alcohol and drug use. Am J Public Health. 2004 Aug; 94(8):1425-30.
    View in: PubMed
    Score: 0.003
  169. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
    View in: PubMed
    Score: 0.003
  170. Stability and convergent validity of the Physical Activity Scale for the Elderly (PASE). J Sports Med Phys Fitness. 2004 Jun; 44(2):186-92.
    View in: PubMed
    Score: 0.003
  171. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004 Mar; 125(3):851-5.
    View in: PubMed
    Score: 0.003
  172. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion. 2004 Feb; 44(2):146-50.
    View in: PubMed
    Score: 0.003
  173. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304.
    View in: PubMed
    Score: 0.003
  174. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.003
  175. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
    View in: PubMed
    Score: 0.003
  176. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6.
    View in: PubMed
    Score: 0.003
  177. Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost. 2003 Jan; 89(1):185-9.
    View in: PubMed
    Score: 0.003
  178. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20.
    View in: PubMed
    Score: 0.003
  179. A youth development approach to profiling sexual abstinence. Am J Health Behav. 2003; 27 Suppl 1:S80-93.
    View in: PubMed
    Score: 0.003
  180. Reliability and validity of the youth asset survey (YAS). J Adolesc Health. 2002 Sep; 31(3):247-55.
    View in: PubMed
    Score: 0.003
  181. Adolescent tobacco use: the protective effects of developmental assets. Am J Health Promot. 2002 Mar-Apr; 16(4):198-205.
    View in: PubMed
    Score: 0.003
  182. Tobacco cessation attitudes and behaviors among Oklahoma high school students. J Okla State Med Assoc. 2002 Mar; 95(3):176-9.
    View in: PubMed
    Score: 0.003
  183. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood. 2002 Jan 15; 99(2):437-42.
    View in: PubMed
    Score: 0.003
  184. An adolescent age group approach to examining youth risk behaviors. Am J Health Promot. 2002 Jan-Feb; 16(3):167-76.
    View in: PubMed
    Score: 0.003
  185. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51.
    View in: PubMed
    Score: 0.003
  186. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001 Mar; 27(6):641-6.
    View in: PubMed
    Score: 0.003
  187. Unintentional platelet removal by plasmapheresis. J Clin Apher. 2001; 16(2):55-60.
    View in: PubMed
    Score: 0.003
  188. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion. 2000 Aug; 40(8):896-901.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.